UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Journal of medicinal chemistry, ISSN 0022-2623, 12/2011, Volume 54, Issue 24, pp. 8251 - 8270
Humans | Cholinesterase Inhibitors - chemistry | Indoles - chemical synthesis | Cholinesterase Inhibitors - chemical synthesis | Isoenzymes - chemistry | Structure-Activity Relationship | Monoamine Oxidase Inhibitors - chemical synthesis | Monoamine Oxidase - chemistry | Butyrylcholinesterase - chemistry | Piperidines - pharmacology | Butyrylcholinesterase - metabolism | Indoles - pharmacology | Binding Sites | Indans - chemistry | Monoamine Oxidase Inhibitors - pharmacology | Piperidines - chemistry | Alzheimer Disease - drug therapy | Models, Molecular | Rats | Electrophorus | Acetylcholinesterase - chemistry | Piperidines - chemical synthesis | Peptide Fragments - chemistry | Animals | Cholinesterase Inhibitors - pharmacology | Horses | Indans - chemical synthesis | Monoamine Oxidase Inhibitors - chemistry | Amyloid beta-Peptides - chemistry | Kinetics | Indoles - chemistry | Acetylcholinesterase - metabolism | Indans - pharmacology | Index Medicus
Journal Article
Journal of medicinal chemistry, ISSN 0022-2623, 03/2014, Volume 57, Issue 6, pp. 2549 - 2567
Stereoisomerism | Humans | Cholinesterase Inhibitors - chemical synthesis | Hippocampus - drug effects | Enzyme Inhibitors - chemical synthesis | Anthraquinones - chemical synthesis | Synapses - metabolism | Long-Term Potentiation - drug effects | Escherichia coli - metabolism | Binding Sites | tau Proteins - antagonists & inhibitors | Aspartic Acid Endopeptidases - antagonists & inhibitors | Mice, Inbred C57BL | Enzyme Inhibitors - pharmacology | Alzheimer Disease - drug therapy | Models, Molecular | Mice, Transgenic | Blood-Brain Barrier - drug effects | Hippocampus - metabolism | Amyloid beta-Peptides - antagonists & inhibitors | Animals | Cholinesterase Inhibitors - pharmacology | Peptide Fragments - antagonists & inhibitors | Anthraquinones - pharmacology | Mice | Amyloid Precursor Protein Secretases - antagonists & inhibitors | Kinetics | Amyloid beta-Protein Precursor - antagonists & inhibitors | In Vitro Techniques | Index Medicus
Journal Article
Bioorganic & medicinal chemistry, ISSN 0968-0896, 06/2017, Volume 25, Issue 12, pp. 3006 - 3017
MAO-B inhibitor | BuChE inhibitor | Alzheimer’s disease | 3,4-Dihydro-2(1H)-quinoline-O-alkylamines | Blood-brain barrier | MAO-A inhibitor | AChE inhibitor | Alzheimer's disease | Monoamine Oxidase Inhibitors - pharmacology | Cholinesterase Inhibitors - pharmacokinetics | Humans | Quinolines - chemistry | Cholinesterase Inhibitors - chemistry | Alzheimer Disease - drug therapy | Electrophorus | Cholinesterase Inhibitors - chemical synthesis | Alzheimer Disease - enzymology | Monoamine Oxidase Inhibitors - chemical synthesis | Quinolines - pharmacology | Blood-Brain Barrier - metabolism | Monoamine Oxidase Inhibitors - pharmacokinetics | Quinolines - chemical synthesis | Quinolines - pharmacokinetics | Animals | Cholinesterase Inhibitors - pharmacology | Butyrylcholinesterase - metabolism | Swine | Drug Design | Monoamine Oxidase Inhibitors - chemistry | Acetylcholinesterase - metabolism | Monoamine Oxidase - metabolism | Oxidases | Alkaloids | Enzyme inhibitors | Surface active agents | Analysis | Resveratrol | Quinoline | Acetylcholine | Drug therapy | High performance liquid chromatography | Index Medicus
Journal Article
Bioorganic chemistry, ISSN 0045-2068, 06/2017, Volume 72, pp. 359 - 366
Bromophenols | Carbonic anhydrase | Bromination | Natural products | Enzyme inhibition | Phenylbutenone | Acetylcholinesterase | Butyrylcholinesterase | Phenols - chemical synthesis | Carbonic Anhydrase Inhibitors - chemistry | Humans | Cholinesterase Inhibitors - chemistry | Carbonic Anhydrase II - metabolism | Biological Products - pharmacology | Cholinesterase Inhibitors - chemical synthesis | Structure-Activity Relationship | Carbonic Anhydrase I - metabolism | Butanones - pharmacology | Carbonic Anhydrase II - antagonists & inhibitors | Dose-Response Relationship, Drug | Butanones - chemical synthesis | Butyrylcholinesterase - metabolism | Molecular Structure | Phenols - pharmacology | Carbonic Anhydrase Inhibitors - chemical synthesis | Carbonic Anhydrase Inhibitors - pharmacology | Butanones - chemistry | Biological Products - chemical synthesis | Biological Products - chemistry | Cholinesterase Inhibitors - pharmacology | Carbonic Anhydrase I - antagonists & inhibitors | Phenols - chemistry | Acetylcholinesterase - metabolism | Enzymes | Isoenzymes | Biological products | Index Medicus
Journal Article
Journal of medicinal chemistry, ISSN 0022-2623, 01/2016, Volume 59, Issue 1, pp. 114 - 131
Humans | Torpedo | Benzofurans - pharmacology | Crystallography, X-Ray | Male | Cholinesterase Inhibitors - chemical synthesis | Structure-Activity Relationship | Benzofurans - chemistry | Tacrine - pharmacology | Drug Design | Behavior, Animal - drug effects | Chemical and Drug Induced Liver Injury - pathology | Tacrine - chemistry | Cell Line | Aspartic Acid Endopeptidases - antagonists & inhibitors | Cell Survival | Alzheimer Disease - drug therapy | Benzofurans - chemical synthesis | Models, Molecular | Nootropic Agents - chemical synthesis | Nootropic Agents - chemistry | Mice, Inbred ICR | Tacrine - chemical synthesis | Animals | Cholinesterase Inhibitors - pharmacology | Mice | Amyloid Precursor Protein Secretases - antagonists & inhibitors | Nootropic Agents - pharmacology | Index Medicus
Journal Article
Bioorganic & medicinal chemistry, ISSN 0968-0896, 02/2014, Volume 22, Issue 4, pp. 1355 - 1361
Alzheimer’s disease | GPx mimics | Cholinesterase inhibitors | Alzheimer's disease | Biocompatible Materials - metabolism | Organoselenium Compounds - chemical synthesis | Antioxidants - metabolism | Humans | Azoles - metabolism | Azoles - therapeutic use | Cholinesterase Inhibitors - chemical synthesis | Organoselenium Compounds - chemistry | Biocompatible Materials - chemical synthesis | Butyrylcholinesterase - chemistry | Cholinesterase Inhibitors - metabolism | Glutathione Peroxidase - chemistry | Butyrylcholinesterase - metabolism | Organoselenium Compounds - therapeutic use | Glutathione Peroxidase - metabolism | Alzheimer Disease - drug therapy | Acetylcholinesterase - chemistry | Antioxidants - chemical synthesis | Azoles - chemical synthesis | Azoles - chemistry | Antioxidants - therapeutic use | Protein Binding | Biocompatible Materials - therapeutic use | Cholinesterase Inhibitors - therapeutic use | Acetylcholinesterase - metabolism | Organoselenium Compounds - metabolism | Peroxidase | Analysis | Amyloid beta-protein | Index Medicus
Journal Article
Bioorganic chemistry, ISSN 0045-2068, 05/2019, Volume 86, pp. 420 - 427
Substituted pyrazole | Enzyme inhibition | Carbonic anhydrase | Acetylcholinesterase | Carbonic Anhydrase Inhibitors - chemistry | Pyrazoles - chemical synthesis | Humans | Cholinesterase Inhibitors - chemistry | Carbonic Anhydrase II - metabolism | Electrophorus | Carbonic Anhydrase Inhibitors - chemical synthesis | Cholinesterase Inhibitors - chemical synthesis | Structure-Activity Relationship | Carbonic Anhydrase Inhibitors - pharmacology | Carbonic Anhydrase I - metabolism | Carbonic Anhydrase II - antagonists & inhibitors | Dose-Response Relationship, Drug | Pyrazoles - chemistry | Animals | Cholinesterase Inhibitors - pharmacology | Carbonic Anhydrase I - antagonists & inhibitors | Carbonic Anhydrase I - isolation & purification | Molecular Docking Simulation | Molecular Structure | Acetylcholinesterase - metabolism | Pyrazoles - pharmacology | Nuclear magnetic resonance spectroscopy | Enzyme inhibitors | Molecular biology | Analysis | Index Medicus
Journal Article
European journal of medicinal chemistry, ISSN 0223-5234, 02/2018, Volume 145, pp. 165 - 190
AChEIs | “Bio-oxidizable” prodrug | Alzheimer | Donepezil analogues | Dihydropyridines - chemistry | Cholinesterase Inhibitors - chemistry | Electrophorus | Cholinesterase Inhibitors - chemical synthesis | Prodrugs - chemistry | Structure-Activity Relationship | Pyridinium Compounds - chemical synthesis | Dose-Response Relationship, Drug | Salts - chemistry | Pyridinium Compounds - pharmacology | Salts - pharmacology | Animals | Cholinesterase Inhibitors - pharmacology | Butyrylcholinesterase - metabolism | Salts - chemical synthesis | Dihydropyridines - pharmacology | Horses | Prodrugs - chemical synthesis | Molecular Docking Simulation | Molecular Structure | Pyridinium Compounds - chemistry | Prodrugs - pharmacology | Acetylcholinesterase - metabolism | Index Medicus | Medicinal Chemistry | Chemical Sciences
Journal Article
Journal of enzyme inhibition and medicinal chemistry, ISSN 1475-6366, 11/2016, Volume 31, Issue sup2, pp. 79 - 85
carbonic anhydrase | butyrylcholinesterase | enzyme inhibition | Acetylcholinesterase | diaryl ethers | Ethers - chemical synthesis | Carbonic Anhydrase Inhibitors - chemistry | Humans | Cholinesterase Inhibitors - chemistry | Carbonic Anhydrase II - metabolism | Ethers - chemistry | Carbonic Anhydrase Inhibitors - chemical synthesis | Cholinesterase Inhibitors - chemical synthesis | Structure-Activity Relationship | Carbonic Anhydrase Inhibitors - pharmacology | Carbonic Anhydrase I - metabolism | Carbonic Anhydrase II - antagonists & inhibitors | Isoenzymes - isolation & purification | Dose-Response Relationship, Drug | Ethers - pharmacology | Cholinesterase Inhibitors - pharmacology | Butyrylcholinesterase - metabolism | Carbonic Anhydrase I - antagonists & inhibitors | Isoenzymes - metabolism | Carbonic Anhydrase I - isolation & purification | Molecular Structure | Carbonic Anhydrase II - isolation & purification | Acetylcholinesterase - metabolism | Isoenzymes - antagonists & inhibitors | Index Medicus
Journal Article
Journal of enzyme inhibition and medicinal chemistry, ISSN 1475-6366, 01/2017, Volume 32, Issue 1, pp. 1174 - 1182
carbonic anhydrase | mercaptobenzothiazole | butyrylcholinesterase | mercaptobenzoxazole | Acetylcholinesterase | Benzoxazoles - pharmacology | Benzothiazoles - pharmacology | Carbonic Anhydrase Inhibitors - chemistry | Humans | Cholinesterase Inhibitors - chemistry | Carbonic Anhydrase Inhibitors - chemical synthesis | Cholinesterase Inhibitors - chemical synthesis | Structure-Activity Relationship | Carbonic Anhydrase Inhibitors - pharmacology | Benzoxazoles - chemical synthesis | Carbonic Anhydrases - metabolism | Dose-Response Relationship, Drug | Benzothiazoles - chemical synthesis | Benzoxazoles - chemistry | Cholinesterase Inhibitors - pharmacology | Thiazoles - chemical synthesis | Butyrylcholinesterase - metabolism | Benzothiazoles - chemistry | Thiazoles - chemistry | Molecular Structure | Thiazoles - pharmacology | Acetylcholinesterase - metabolism | Enzymes | Chemistry | Isoenzymes | Carbon dioxide | Physiology | Biochemistry | Carbonic anhydrase I | Sulfur | Pharmaceutical sciences | Alcohols | Index Medicus
Journal Article
Journal of enzyme inhibition and medicinal chemistry, ISSN 1475-6366, 11/2016, Volume 31, Issue sup3, pp. 1 - 9
carbonic anhydrase | butyrylcholinesterase | enzyme inhibition | Acetylcholinesterase | antioxidant activity | Antioxidants - chemistry | Carbonic Anhydrase Inhibitors - chemistry | Pyrimidines - chemical synthesis | Humans | Cholinesterase Inhibitors - chemistry | Carbonic Anhydrase II - metabolism | Carbonic Anhydrase Inhibitors - chemical synthesis | Cholinesterase Inhibitors - chemical synthesis | Structure-Activity Relationship | Antioxidants - chemical synthesis | Antioxidants - pharmacology | Carbonic Anhydrase Inhibitors - pharmacology | Pyrimidines - pharmacology | Carbonic Anhydrase I - metabolism | Carbonic Anhydrase II - antagonists & inhibitors | Pyrimidines - chemistry | Dose-Response Relationship, Drug | Cholinesterase Inhibitors - pharmacology | Butyrylcholinesterase - metabolism | Carbonic Anhydrase I - antagonists & inhibitors | Molecular Structure | Acetylcholinesterase - metabolism | Index Medicus
Journal Article
European journal of medicinal chemistry, ISSN 0223-5234, 04/2015, Volume 94, pp. 348 - 366
Acetylcholinesterase inhibitors | Aβ aggregation inhibitors | Multifunctional agents | Metal-chelating agents | Alzheimer's disease | Scutellarein-O-alkylamines | Ab aggregation inhibitors | Amines - chemistry | Antioxidants - chemistry | Humans | Cholinesterase Inhibitors - chemistry | Cholinesterase Inhibitors - chemical synthesis | Structure-Activity Relationship | PC12 Cells | Apigenin - chemistry | Dose-Response Relationship, Drug | Apigenin - chemical synthesis | Scopolamine Hydrobromide | Amyloid beta-Peptides - metabolism | Drug Design | Molecular Structure | Peptide Fragments - metabolism | Hydrogen Peroxide - pharmacology | Alzheimer Disease - drug therapy | Models, Molecular | Rats | Amines - chemical synthesis | Antioxidants - chemical synthesis | Antioxidants - pharmacology | Amyloid beta-Peptides - antagonists & inhibitors | Animals | Memory Disorders - drug therapy | Cholinesterase Inhibitors - pharmacology | Peptide Fragments - antagonists & inhibitors | Mice | Amines - pharmacology | Hydrogen Peroxide - antagonists & inhibitors | Acetylcholinesterase - metabolism | Apigenin - pharmacology | Memory Disorders - chemically induced | Surface active agents | Drug therapy | Analysis | Index Medicus
Journal Article
Journal of medicinal chemistry, ISSN 0022-2623, 11/2005, Volume 48, Issue 23, pp. 7223 - 7233
Psychology. Psychoanalysis. Psychiatry | Psychopharmacology | Pharmacology. Drug treatments | Biological and medical sciences | Medical sciences | Neuropharmacology | Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) | Cholinesterase Inhibitors - toxicity | Humans | Cholinesterase Inhibitors - chemistry | Cholinesterase Inhibitors - chemical synthesis | Structure-Activity Relationship | Fluorometry | Butyrylcholinesterase - chemistry | Cattle | Drug Design | Erythrocytes - enzymology | Tacrine - analogs & derivatives | Binding Sites | Dimerization | Tacrine - chemistry | Alzheimer Disease - drug therapy | Models, Molecular | Acetylcholinesterase - chemistry | Nootropic Agents - chemical synthesis | Nootropic Agents - chemistry | Nootropic Agents - toxicity | Tacrine - chemical synthesis | Amyloid beta-Peptides - antagonists & inhibitors | Animals | Cell Line, Tumor | Protein Binding | Amyloid beta-Peptides - chemistry | Tacrine - toxicity | Index Medicus
Journal Article
Bioorganic chemistry, ISSN 0045-2068, 04/2019, Volume 85, pp. 128 - 139
Enzyme inhibition | Carbonic anhydrase | Acetylcholinesterase | Bromination | Bromophenol | Molecular docking | Bromobenzenes - chemical synthesis | Cholinesterase Inhibitors - pharmacokinetics | Carbonic Anhydrase Inhibitors - pharmacokinetics | Cholinergic Antagonists - chemical synthesis | Biological Products - pharmacokinetics | Phenols - chemical synthesis | Humans | Carbonic Anhydrase II - metabolism | Cholinesterase Inhibitors - chemical synthesis | Carbonic Anhydrase I - metabolism | Butyrylcholinesterase - chemistry | Cholinesterase Inhibitors - metabolism | Butyrylcholinesterase - metabolism | Cholinergic Antagonists - pharmacokinetics | Bromobenzenes - metabolism | Carbonic Anhydrase Inhibitors - chemical synthesis | Acetylcholinesterase - chemistry | Carbonic Anhydrase I - chemistry | Phenols - metabolism | Bromobenzenes - pharmacokinetics | Cholinergic Antagonists - metabolism | Biological Products - chemical synthesis | Phenols - pharmacokinetics | Biological Products - metabolism | Protein Binding | Molecular Docking Simulation | Carbonic Anhydrase Inhibitors - metabolism | Acetylcholinesterase - metabolism | Carbonic Anhydrase II - chemistry | Hydroxides | Isoenzymes | Benzene | Resveratrol | Index Medicus
Journal Article
Molecules (Basel, Switzerland), ISSN 1420-3049, 2018, Volume 23, Issue 2, p. 250
Multitarget ligands | Monoamine oxidase inhibitors | Cholinesterase inhibitors | Coumarin | Aromatase inhibitors | Biochemistry & Molecular Biology | Physical Sciences | Chemistry | Life Sciences & Biomedicine | Chemistry, Multidisciplinary | Science & Technology | Humans | Enzyme Inhibitors - pharmacology | Alzheimer Disease - drug therapy | Aromatase - metabolism | Parkinson Disease - drug therapy | Structure-Activity Relationship | Nootropic Agents - chemical synthesis | Enzyme Inhibitors - chemical synthesis | Aromatase - chemistry | Coumarins - pharmacology | Monoamine Oxidase - chemistry | Neuroprotective Agents - chemical synthesis | Neuroprotective Agents - pharmacology | Cholinesterases - chemistry | Biotransformation | Coumarins - chemical synthesis | Drug Design | Molecular Structure | Cholinesterases - metabolism | Nootropic Agents - pharmacology | Monoamine Oxidase - metabolism | Transformation | Neurodegenerative diseases | Biosynthesis | Pharmacology | Amine oxidase (flavin-containing) | Cholinesterase | Diseases | Neurological diseases | Inhibitors | Enzyme inhibitors | Reviews | Pathways | Bioactive compounds | Aromatase | Chemists | Scaffolds | Index Medicus
Journal Article